Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 1999

View Archived Issues

Company Profile: SLIL Biomedical

Tremacamra reduces cold symptoms, opens new avenues in rhinovirus research

Connetics receives milestone payment from Suntory

Myriad Genetics delivers four potential drug targets for dementia to Bayer

Inflazyme signs collaborative agreement with HMR for asthma and allergy therapeutics

Schering AG: Annual Report 1998

Innovax acquires oral microsphere technology

Positive findings from phase III trial of anti-IgE for allergic rhinitis

Schering expands antibody agreement with Medarex

VIMRx and Nexell restructure relationship with Baxter

SDZ-RAD prolongs survival of pig-to-primate xenotransplantation

Anti-CD3 MAb HuM291 suppresses transplant rejection in clinical trials

Azimilide reduces recurrence in PSVT patients

Novel vitronectin receptor antagonists in early development at SB

New hydroxamic acid-based MMP and TNF-alpha production inhibitors from American Cyanamid

BASF patents new tyrosine kinase inhibitors for hyperproliferative and angiogenic disorders

Lysophosphatidylic acid derivatives for local or systemic treatment of bone metabolic disorders

Inhibitors of key kynurenine pathway enzyme disclosed by Pharmacia & Upjohn

Alosetron provides significant relief of pain and improves bowel function in patients with IBS

Novel agents from Dr. Reddy with hypolipidemic, hypoglycemic and HDL cholesterol-increasing effects

Potent, water-soluble paclitaxel analogue in early clinical trials presented by BMS at ASCO meeting

Phase I results for endothelin antagonist discussed at ASCO meeting; phase II trials under way

RSR-13, an allosteric hemoglobin modifier, evaluated in GBM in combination with cranial radiotherapy

Merger of Sanofi and Synthelabo effective retroactively as of January 1, 1999

Pegylated G-CSF from Roche compared to filgrastim in chemotherapy-treated breast cancer patients

Triangle Pharmaceuticals: Q1 1999 highlights

Encouraging phase I/II data reported at oncology meeting for Incel

News from DDW: dexloxiglumide in the treatment of IBS

Novartis develops new enteric-coated formulation of mycophenolic acid

Transplantation news: tresperimus is a potent immunosuppressant with a novel mechanism of action

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...